ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
-6.24%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$171M
AUM Growth
+$171M
Cap. Flow
-$22.3M
Cap. Flow %
-13.09%
Top 10 Hldgs %
97.4%
Holding
14
New
–
Increased
3
Reduced
5
Closed
1

Top Buys

1
BPMC
Blueprint Medicines
BPMC
$1.85M
2
QURE icon
uniQure
QURE
$255K
3
SLN
Silence Therapeutics
SLN
$174K

Top Sells

1
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
$15.3M
2
MRUS icon
Merus
MRUS
$3.81M
3
ARWR icon
Arrowhead Research
ARWR
$2.16M
4
RGNX icon
Regenxbio
RGNX
$1.26M
5
ARVN icon
Arvinas
ARVN
$1.23M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BPMC
1
DELISTED
Blueprint Medicines
BPMC
$28M 11.61%
622,829
+41,061
+7% +$1.85M
ARWR icon
2
Arrowhead Research
ARWR
$3.05B
$25.9M 10.72%
1,018,474
-85,041
-8% -$2.16M
MRUS icon
3
Merus
MRUS
$4.98B
$22.5M 9.34%
1,225,109
-207,000
-14% -$3.81M
KYMR icon
4
Kymera Therapeutics
KYMR
$2.95B
$17.8M 7.38%
601,325
-28,086
-4% -$832K
ARVN icon
5
Arvinas
ARVN
$568M
$17.2M 7.12%
628,941
-45,000
-7% -$1.23M
RGNX icon
6
Regenxbio
RGNX
$451M
$15.7M 6.51%
831,014
-66,670
-7% -$1.26M
QURE icon
7
uniQure
QURE
$896M
$12.8M 5.32%
637,526
+12,672
+2% +$255K
GMAB icon
8
Genmab
GMAB
$15.3B
$9.17M 3.8%
242,848
– –
ARGX icon
9
argenx
ARGX
$43.6B
$8.94M 3.71%
24,000
– –
SLN
10
Silence Therapeutics
SLN
$227M
$8.14M 3.37%
1,312,233
+28,100
+2% +$174K
PVLA
11
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$4.44M 1.84%
4,552,876
– –
QQQ icon
12
Invesco QQQ Trust
QQQ
$364B
– –
0
– –
XBI icon
13
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –
AMYT
14
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
– –
-2,098,993
Closed -$15.3M